Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck carcinomas

被引：0
|
作者：
Allal, AS
Zwahlen, D
Becker, M
Dulguerov, P
Mach, N
机构：
[1] Univ Hosp Geneva, Div Radiat Oncol, Geneva, Switzerland
[2] Univ Hosp Geneva, Div Radiol, Geneva, Switzerland
[3] Univ Hosp Geneva, Div H&N Surg, Geneva, Switzerland
[4] Univ Hosp Geneva, Div Med Oncol, Geneva, Switzerland
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2005年 / 181卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [41] Is there a benefit of accelerated hyperfractionated radiotherapy for advanced head and neck carcinomas in women?
    Staar, S
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (05) : 286 - 287
  • [42] A Phase II Study of Docetaxel, Cisplatin and 5-Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas
    Ansari, M.
    Omidvari, S.
    Mosalaei, A.
    Ahmadloo, N.
    Mosleh-Shirazi, M. A.
    Mohammadianpanah, M.
    [J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2011, 13 (03) : 187 - 191
  • [43] CONCOMITANT CISPLATIN AND HYPERFRACTIONATED EXTERNAL BEAM IRRADIATION FOR ADVANCED MALIGNANCY OF THE HEAD AND NECK
    FONTANESI, J
    BECKFORD, NS
    LESTER, EP
    KAVANAUGH, KT
    TAI, D
    EDDY, T
    KUN, LE
    [J]. AMERICAN JOURNAL OF SURGERY, 1991, 162 (04): : 393 - 396
  • [44] PET evaluation of hypoxia and response in locally advanced head and neck cancer treated on a phase I trial of radiotherapy, tirapazamine and cisplatin
    Rischin, D
    Hicks, R
    Peters, L
    Hughes, P
    Binns, D
    Maisano, R
    Harvey, E
    von Roemeling, R
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 126 - 126
  • [45] Definitive Altered Fractionation Radiotherapy and Concomitant Weekly Cisplatin for Locally Advanced Head and Neck Cancer
    Boulmay, Brian C.
    Chera, Bhishamjit S.
    Morris, Christopher G.
    Kirwan, Jessica
    Riggs, Charles E.
    Lawson, Michael
    Mendenhall, William M.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 488 - 491
  • [46] Phase I trial of concurrent chemo radiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori, H
    Tsukuda, M
    Ishitoya, J
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Ono, M
    Hirose, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 503S - 503S
  • [47] Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
    Jacinto, Alexandre Arthur
    Batalha Filho, Eronides Salustiano
    Viana, Luciano de Souza
    De Marchi, Pedro
    Capuzzo, Renato de Castro
    Gama, Ricardo Ribeiro
    Boldrini Junior, Domingos
    Santos, Carlos Roberto
    Junqueira Pinto, Gustavo Dix
    Dias, Josiane Mourao
    Canton, Heloisa Pelisser
    Carvalho, Raiany
    Radicchi, Lucas Augusto
    Bentzen, Soren
    Zubizarreta, Eduardo
    Carvalho, Andre Lopes
    [J]. BMC CANCER, 2018, 18
  • [48] Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
    Alexandre Arthur Jacinto
    Eronides Salustiano Batalha Filho
    Luciano de Souza Viana
    Pedro De Marchi
    Renato de Castro Capuzzo
    Ricardo Ribeiro Gama
    Domingos Boldrini Junior
    Carlos Roberto Santos
    Gustavo Dix Junqueira Pinto
    Josiane Mourão Dias
    Heloisa Pelisser Canton
    Raiany Carvalho
    Lucas Augusto Radicchi
    Soren Bentzen
    Eduardo Zubizarreta
    Andre Lopes Carvalho
    [J]. BMC Cancer, 18
  • [49] Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally-advanced head and neck cancer: a randomized phase II trial
    Vozy, A.
    Cuenca, X.
    [J]. ONCOLOGIE, 2016, 18 (06) : 429 - 430
  • [50] Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer
    Rischin, D
    Peters, L
    Hicks, R
    Hughes, P
    Fisher, R
    Hart, R
    Sexton, M
    D'Costa, I
    von Roemeling, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 535 - 542
12345